What is acute myeloid leukemia (AML)?
Produced in collaboration with The Leukemia & Lymphoma Society.
Support for this patient education program was provided by Pfizer Inc.
Acute myeloid leukemia (AML) is a rare and aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. Trustworthy education is one of the most important and empowering tools for patients and caregivers, whether they're facing a new diagnosis or have already begun the battle.
If you or someone you care for has AML, join our interactive education program originally recorded live on July 24, 2017 with a panel of AML experts.
Watch the full program or choose from the chapters below.
Chapters and Extras
How do test results help me and my doctors?
What are my options for treatment?
Where do I go for self-care information and support?
Hundreds of questions came in before and during the live program. Watch this extra footage of the panel answering some they didn't get to during the live broadcast.
David P. Steensma, MD, FACP
Harvard Medical School
David P. Steensma, MD, FACP is an Associate Professor of Medicine at Harvard Medical School, consulting physician at Brigham & Women’s Hospital, and a faculty member in the Division of Hematological Malignancies at Dana-Farber Cancer Institute in Boston, Massachusetts. He earned his MD from the University of Chicago’s Pritzker School of Medicine. Dr. Steensma has more than 300 publications in peer-reviewed journals that include the New England Journal of Medicine, Blood, and Leukemia.
Michelle Rajotte, LMSW
The Leukemia & Lymphoma Society
Michelle Rajotte, LMSW is currently the Associate Director of The Leukemia & Lymphoma Society’s Information Resource Center (IRC) and has worked for The Leukemia & Lymphoma Society (LLS) for almost 12 years. She started as an Information Specialist back in 2005. As part of her role as Associate Director, she assists and educates those touched by blood cancers when they reach out to LLS for resources, information and support. Michelle has a Masters in Social Work from NYU and a Bachelor of Arts in Psychology from Quinnipiac University.
Katherine Edmonds, ARNP
Dana-Farber Cancer Institute
Katherine Edmonds, ARNP is a nurse practitioner in the leukemia program at the Dana-Farber Cancer Institute. Prior to her current role, Katherine worked as a registered nurse at Dana-Farber in the Hematologic Malignancy Department while she completed her master’s degree at the MGH Institute of Health Professions. Katherine is a graduate of NYU nursing school (2006) and worked as a registered nurse at Memorial Sloan Kettering Cancer Center from 2006-2009 in the ICU.